A weekly podcast powered by CURE, on what we do best: provide Cancer Updates Research and Education.
Each week, you'll hear from patients, survivors, caregivers, advocates or health care professionals regarding the entire cancer continuum - ranging from specific cancer types to side effects to the psychological strains a cancer diagnosis can have on an individual and their loved ones.
As the largest consumer magazine in the United States for patient, survivors and caregivers, we strive to combine science with humanity to make cancer understandable.
To learn more, you can also visit us on Facebook, Twitter and Instagram!
📻 Siste episoder av Cancer Horizons
Her er de nyeste episodene tilgjengelige via RSS-feeden:
S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments (00:14:50)
CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...
S7 Ep1: The Importance of Spotting Endometrial Cancer (00:10:25)
Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care (00:19:35)
S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine (00:07:46)
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...
S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research (00:10:12)
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...
S6 Ep20: FDA Approvals from February 2024 (00:06:26)
Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...
S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development (00:09:03)
Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...
S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More (00:07:13)
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...
S6 Ep17: FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment (00:09:13)
Last week, we saw some research regarding how a popular tool used to plan breast cancer treatment may be misguiding therapy for Black women, as well as an update on when we can expect to see a new can...
S6 Ep16: Highlights from the Gastrointestinal and Genitourinary Cancer Conferences (00:08:57)
It’s been a busy few weeks here at CURE® and in the oncology space as a whole, as the last two weekends had back-to-back meetings: the American Society of Clinical Oncology’s Gastrointestinal Cancers ...
S6 Ep15: Prostate Cancer Headlines, CAR-T Warnings and Laughter Therapy (00:07:29)
Last week, we saw some big headlines in the oncology space, from Dexter Scott King’s death from prostate cancer and MLB Hall-of-Famer Ryne Sandberg announcing that he was diagnosed with the disease.
...
S6 Ep14: How a Cancer Journey Connects Oncologist to His Patients (00:07:58)
Often, receiving a cancer diagnosis can require a crash course in oncology that few patients ever expected to take.
For colorectal cancer specialist Dr. Dustin Deming, the ACI/Schwenn Family associat...
S6 Ep13: A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More (00:10:25)
It wasn’t even two weeks into the new year when the Food and Drug Administration made their first FDA approval. In this case, it was a Keytruda regimen for certain patients with gynecologic cancers. W...
S6 Ep12: FDA Gives Cancer Drug Updates, Prostate Cancer Trial Enrolls Patients (00:10:46)
This week in oncology news, we saw a few decisions from the Food and Drug Administration, ranging from the agency agreeing to review a drug and potentially grant it a full approval to their citing man...
S6 Ep11: ‘Stand Up For Yourself’: Facing Thyroid Cancer With Urgency, Positivity (00:11:29)
Kate Rice is proof of the power of persistence and positivity while navigating a cancer journey.
Rice, an award-winning journalist, received a diagnosis of stage 4 anaplastic thyroid cancer in Octobe...
S6 Ep10: FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis (00:07:11)
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.
Notably, we have a clinical trial hold for a lung cancer drug, a trial t...
S6 Ep9: Top Cancer Headlines from 2023: From Jimmy Buffett’s Death to the Chemo Shortage (00:07:44)
The year 2023 has come and gone, and we figured that now is the perfect time to look back on some of the top cancer-related stories from the year.
Vitamin D May Impact Colorectal Cancer Outcomes...
S6 Ep8: FDA Approves 3 Treatments, Cancer Vaccine Shows Promise (00:08:16)
The FDA is certainly staying busy as 2023 comes to a close, approving three treatments for patients with cancer last week alone.
Additionally, exciting study findings were released regarding a cancer...
S6 Ep7: Conference Highlights from the 2023 ASH Annual Meeting (00:06:46)
This past weekend, the CURE® staff was busy covering the American Society of Hematology (ASH) Annual Meeting.
ASH is the largest blood cancer conference in the country, and thousands of abstracts wer...
S6 Ep6: Conference Highlights from SABCS (00:07:23)
The last week was a busy one for us here at CURE® and across the oncology space in general. There were two major meetings we covered: the San Antonio Breast Cancer Symposium and the American Society o...
S6 Ep5: Top Headlines on CAR-T Cell Therapy (00:04:58)
Blood cancer treatments — and one treatment type, in particular — were the point of much discussion last week. The FDA said that it is investigating instances of secondary malignancies in patients wit...
S5 Ep35: Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer (00:08:27)
For patients with cervical cancer who are negative for high-risk human papillomavirus (HPV) with normal or low-grade cytology, a prolonged follow-up interval of six months could be offered six to 24 m...
S6 Ep4: Diabetes Affects CRC Outcomes, Vitamin D May Prevent Neuropathy (00:10:58)
The end of the year typically brings a number of FDA approvals, and 2023 is no different. Last week, the Food and Drug Administration approved a new drug, Augyro (repotrectinib) for the treatment of p...
S5 Ep34: ‘Queer Eye’ Star Thom Filicia on Bone Marrow Donation and Myelofibrosis (00:08:50)
It’s been a decade since Thom Filicia, acclaimed interior designer and former co-star of “Queer Eye for the Straight Guy,” served as a bone marrow donor for his brother, Jules, who had received a diag...
S6 Ep3: Cancer and Burn Pits, FDA Updates and Provider A Doctor’s on Medicare (00:09:04)
Last week was Veterans’ Day, and for some individuals in the armed service, that means reflecting back on their service, as well as the potential cause of their cancer. For both print and web-first fe...
Side 1 av 6
Cancer Horizons - Gratis RSS Feed for Norsk Podcast | OpenPodMe | OpenPodMe - Åpen RSS for Norske Podcaster
